Sensititre MYCOTB MIC Plate for Testing Mycobacterium tuberculosis Susceptibility to First- and Second-Line Drugs
Jongseok Lee(International Tuberculosis Research Center), Moses Joloba(Ministry of Health), Clifton E. Barry(National Institutes of Health), Sandra Armakovitch(Boston University), Derek T. Armstrong(Johns Hopkins University), Willy Ssengooba(Makerere University), Carolyn Namaganda(Makerere University), Francis Mumbowa, David Alland(Rutgers, The State University of New Jersey), Yeuni Yu(International Tuberculosis Research Center), G. Chien(Boston University), Germine Nakayita(Makerere University), Jerrold J. Ellner(Rutgers, The State University of New Jersey), Sang-Nae Cho(International Tuberculosis Research Center), Jeong-ae Park(International Tuberculosis Research Center), Laura E. Via(National Institutes of Health), Susan E. Dorman(Medical University of South Carolina), Gerald Mboowa(African Union Commission)
Cited by 108
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
|The Lancet Infectious Diseases|2017|688
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
|New England Journal of Medicine|2021|548